Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Özgür Kartal is active.

Publication


Featured researches published by Özgür Kartal.


Allergologia Et Immunopathologia | 2008

The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers

Mustafa Gulec; Zafer Caliskaner; Y. Tunca; Sami Ozturk; E. Bozoglu; D. Gul; Fuat Erel; Özgür Kartal; Mehmet Karaayvaz

BACKGROUND Angiotensin Converting Enzyme inhibitors (ACEi) may cause angioedema, with an incidence of 0.1 % to 1 %, which may be life-threatening. ACEi induce angioedema by increasing the levels of bradykinin. Angiotensin II receptor blockers (ATRB), have a pharmacological profile similar to ACEi. The polymorphism of the ACE gene is based on the presence or absence of a 287-bp element on intron 16 on chromosome 17. The plasma level of ACE is related to gene polymorphism. ACE level in genotype DD is double that in genotype II. OBJECTIVE The aim of this study was to investigate whether the relationship between ACE gene polymorphism and ACEi induced angioedema is present or not. METHODS ACE gene polymorphism was investigated in patients with angioedema due to the use of ACEi or ATRB (n:32, group 1), in patients receiving ACEi or ATRB without angioedema (n:46, group 2), and healthy controls (n:96, group 3). RESULTS ID polymorphism was the most frequent genotype in all groups, without any significant difference among the groups (p:0.868). ACE gene polymorphism was not related with the drugs used (ACEi or ATRB), localisation of angioedema, and female sex, in group 1. CONCLUSION Our results showed that ACE gene polymorphism has no effect on ACEi or ATRB induced angioedema.


Allergologia Et Immunopathologia | 2007

Serum Leptin Levels and Lipid Profiles in Patients with Allergic Rhinitis and Mild Asthma

Fuat Erel; Mustafa Gulec; Özgür Kartal; Zafer Caliskaner; Sami Ozturk; Halil Yaman; Y Kurt; E Gocgeldic; Fatih Ors; Mehmet Karaayvaz

BACKGROUND Despite improved understanding of the pathophysiology of allergic rhinitis and asthma, the effect of serum leptin level is still controversial. Only a few studies have been performed to investigate the serum leptin levels in allergic rhinitis and asthma, and contradictory results have been observed. OBJECTIVE We aimed to investigate the association between leptin, lipid profiles and allergic rhinitis and mild asthma, and to determine whether inhaled and/or intranasal steroids affect the leptin levels. PATIENTS AND METHODS We studied 43 patients with allergic rhinitis (10 of with mild asthma) (mean age 29.81, range 18-45 yr) and 32 volunteers as a control group (mean age 30.53, range 20-45 yr). RESULTS Serum leptin levels in patients were 8.49 +/- 10.76 microg/ml, and did not differ from volunteers 5.42 +/- 6.63 microg/ml. (p > 0.05). We found a direct link between increased body mass index (BMI) and serum leptin levels (p = 0.008). No association was seen between leptin and triglyceride, HDL-cholesterol, VLDL-cholesterol, eosinophil, total IgE (p > 0.05); except for total cholesterol and LDL-cholesterol (p < 0.05). Although, no correlation between allergic rhinitis and mild asthma and serum level of leptin was shown, these parameters and age correlations were stronger in female than in male (p = 0.39 for male and p = 0.011 for female), and also found direct link between increased BMI and sex and patients group (p = 0.008 for male and p = 0.0001 for female). We also determined that there was no effect of inhaled and/or intranasal steroids statistically on serum leptin levels. CONCLUSION Our data demonstrate that the serum levels of leptin and lipid profiles on allergic rhinitis and mild asthma were not different than those in controls.


Immunopharmacology and Immunotoxicology | 2015

Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.

Özgür Kartal; Mustafa Gulec; Zafer Caliskaner; Ugur Musabak; Osman Sener

Abstract Context: Although subcutaneous allergen immunotherapy (SCIT) is effective in allergic rhinitis (AR) and asthma, it carries a risk of local and systemic adverse reactions. Objective: The aim of this study was to evaluate the rates and clinical characteristics of local and systemic reactions (LR and SR), and to identify their relation of demographic features, allergen extracts and diagnosis. Materials and methods: This study analyzed the administration of SCIT from 1983 to 2013; involving 1816 patients affected by allergic asthma and/or AR. Results: The rates of SR from SCIT were 0.078% per injection and 9% per patient. According to the World Allergy Organization 2010 grading system, 91 grade 1 reactions (44%), 67 grade 2 reactions (32.3%), 33 grade 3 reactions (16%) and 16 grade 4 reactions (7.7%) were seen. There was no fatal outcome from any of the SRs. Risk factors for a SR included: aluminium-adsorbed extract, pollen-containing vaccines, large LR and recurrent (≥2) LRs. The total LR rates were 0.062% per injection and 5.2% per patient; the small LR rates were 0.027% per injection and 2.3% per patient, and the large LR rate were 0.035% per injection and 2.9% per patient. Female gender, depot extracts, calcium phosphate-adsorbed extract and pollen vaccines were identified as risk factors for LR. Conclusion: The analysis of our data over a 30-year period confirmed that SCIT with inhalant allergens conducted strictly according to the standard protocols and when administrated by experienced staff is a safe method of treatment with only a few side-effects.


Human & Experimental Toxicology | 2012

A case of textile dermatitis due to disperse blue on the surgical wound

Zafer Caliskaner; Özgür Kartal; Abdullah Baysan; Sait Yesillik; Fevzi Demirel; Mustafa Gulec; Osman Sener

Disperse blue (DB) 106 and DB 124 are the most frequent fabric dye allergens inducing textile dermatitis, but contact allergy to them may easily undiagnosed because the clinical picture usually needs high index of suspicion. We present the case of a 35-year-old woman who was referred for a recurred lesion over the incision scar of right total hip replacement surgery, which did not respond to treatment with povidone–iodine, mupirocin, and rifampicin. Patch testing, conducted with a European standard series and therapeutics that were used in the treatment of the lesion, revealed a positive reaction to dispersion mix blue 106/124. The patient was questioned in detail and reported that she has been wearing dark-colored synthetic panties for long years. The correlation was done between the positive antigen in the patch test and the clinical findings. The patient was treated with a corticosteroid cream for 2 weeks. She did not wear any dark-colored synthetic panties afterward and no flare-up was seen in the follow-up period. In this report, we emphasize the importance of detailed questioning of patients and that contact dermatitis should be considered potential cause of dermatitis at skin sites where the barrier function is compromised.


Annals of Dermatology | 2012

Acute Urticaria Associated with Thyroid Papillary Carcinoma: A Case Report

Özgür Kartal; Baysan Abdullah; Ersoy Ramazan; Gulec Mustafa; Calıskaner Zafer; Sener Osman

Although there are several studies showing the association between cancer and urticaria, the mechanisms by which these events occur are not yet known. In this report, a case of acute urticaria with a diagnosis of thyroid papillary carcinoma is presented. Disappearance of treatment-resistant urticarial lesions after thyroidectomy suggests that this association was not a coincidence. The fact that urticaria which was nonresponsive to treatment disappeared spontaneously as a result of tumorectomy, strongly suggests that this association is not a coincidence. To our knowledge, this is the first report of the coexistence of acute urticaria and thyroid papillary carcinoma. This case provides further support that detailed history taking and a thorough physical examination are of paramount importance.


Indian Journal of Dermatology, Venereology and Leprology | 2011

Chronic urticaria in patients with autoimmune thyroiditis: Significance of severity of thyroid gland inflammation

Mustafa Gulec; Özgür Kartal; A. Zafer Çalışkaner; Mahmut Yazici; Halil Yaman; Sami Ozturk; Osman Sener

BACKGROUND There is a clear association between autoimmune thyroiditis (AT) and chronic urticaria/angioedema (CUA). However, not all patients with AT demonstrate urticaria. AIMS The aim of the study was to investigate in which patients with AT did CUA become a problem. A sensitive inflammation marker, neopterine (NP) was used to confirm whether the severity of inflammation in the thyroid gland was responsible for urticaria or not. METHODS Neopterine levels were assessed in patients with AT with urticaria and without urticaria. Furthermore, levels were compared in relation to pre and post levothyroxine treatment. Twenty-seven patients with urticaria (Group 1) and 28 patients without urticaria (Group 2) were enrolled in the study. A course of levothyroxine treatment was given to all patients, and urine neopterine levels before and after the trial were obtained. RESULTS All patients completed the trial. Mean age in Group 1 and Group 2 was similar (35.70 ± 10.86 years and 38.36 ± 10.38 years, respectively) (P=0.358). Pre-treatment urine neopterine levels were significantly higher in Group 1 (P=0.012). Post-treatment levels decreased in each group, as expected. However, the decrease in the neopterine level was insignificant in the patients of Group 2 (P=0.282). In Group 1, a significant decrease in post-treatment neopterine levels (P=0.015) was associated with the remission of urticaria. CONCLUSION In patients with CUA and AT, pre-treatment elevated levels of NP, and its decrease with levothyroxine treatment along with symptomatic relief in urticaria, may be evidence of the relationship between the degree of inflammation in thyroid and presence of urticaria.


The Korean Journal of Internal Medicine | 2011

Acute Generalized Exanthematous Pustulosis Due to Oral Use of Blue Dyes

Osman Sener; Osman Köse; Özgür Kartal; Mukerrem Safali

Acute generalized exanthematous pustulosis is a rare severe pustular cutaneous adverse reaction characterized by a rapid clinical course with typical histological findings. It is accompanied by fever and acute eruption of non-follicular pustules overlying erythrodermic skin. The causative agents are most frequently antibacterial drugs. We present a patient with acute generalized exanthematous pustulosis caused by methylene blue and indigotin dyes.


Wiener Klinische Wochenschrift | 2016

Erratum to: Killer-cell immunoglobulin-like receptor and human leukocyte antigen-C genes in common variable immunodeficiency

Özgür Kartal; Ugur Musabak; Sait Yesillik; Rahsan Ilikci Sagkan; Aysel Pekel; Fevzi Demirel; Abdullah Baysan; Ali Selçuk; Mustafa Gulec; Osman Şener

SummaryBackgroundWe aimed herein to investigate the killer-cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA)-C alleles in patients with common variable immunodeficiency (CVID), and to reveal their differences from those in healthy population.MethodsIn all, 18 patients who have been diagnosed with CVID and 15 living donors of kidney transplant recipients were enrolled in the study. Polymerase chain reaction-sequence-specific primer (PCR-SSP) typing method was used in molecular genetic analysis. The frequencies of the genes in the study groups were statistically compared with each other using chi-square or Fisher exact tests, whichever were appropriate.ResultsAlthough there was no significant difference between both study groups with respect to distribution of KIR and HLA-C2 group genes, HLA-Cw7 allele frequency in patients with CVID was significantly lower than that in healthy population (P = 0.008).ConclusionThis present study results support that HLA-Cw7 allele, an inhibitor of KIR ligand, may play a role in the pathogenesis of CVID.


Clinical and Translational Allergy | 2014

An unexpected allergic reaction with Saccharomyces boulardii: a case report

Özgür Kartal; Fevzi Demirel; Abdullah Baysan; Mustafa Gulec; Sait Yesillik; Metin Uyanýk; Ugur Musabak; Osman Sener

Saccharomyces boulardii (S.boulardii), known as a nonpathogenic yeast probiotic shows its efficacy in inflammatory and infectious diseases of the gastrointestinal tract safely. This report presents an allergic reaction and positive skin test in a patient who takes S.boulardii as an antidiarrheal therapy.


Clinical and Translational Allergy | 2014

Multifocal fixed drug eruption due to ornidazole

Fevzi Demirel; Abdullah Baysan; Sait Yesillik; Özgür Kartal; Mustafa Gulec; Ugur Musabak; Osman Sener

Ornidazole, a synthetic nitroimidazole derivative, is widely used in clinical practice. Ornidazol has low rate of side effects, but sometimes may cause significant allergic reactions such as fixed drug eruption (FDE). We describe a case of multifocal FDE caused by ornidazole.

Collaboration


Dive into the Özgür Kartal's collaboration.

Top Co-Authors

Avatar

Mustafa Gulec

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Osman Sener

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Osman Şener

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Sami Ozturk

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ugur Musabak

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fevzi Demirel

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Fuat Erel

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Sait Yesillik

Military Medical Academy

View shared research outputs
Researchain Logo
Decentralizing Knowledge